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1. Introduction 
During pregnancy, many changes take place in both systemic and local environments 
leading to a significant increase in the severity of gingivitis. In recent years, many studies 
have assessed the changes that occur within the gingival tissue during pregnancy and their 
potential impact on the foetus.  
Pregnancy is defined as a state that includes fertilization, implantation and embryonic and 
fetal growth that ends with the birth of a baby after 280 days or 40 weeks. Pregnancy 
gingivitis presents as gingival erythema, enlargement and bleeding. Epidemiological studies 
have shown that the prevalence of gingivitis increases during pregnancy when compared to 
control groups. The evidence indicates that hormonal changes affect the rate of cell turnover 
of the gingival tissues, inducing several microbiological changes in the subgingival flora and 
immunosuppression of the immune system. 
New evidence supports an association between the periodontal status and complications 
during pregnancy. Some countries have developed   policies and practice guidelines that 
recommend oral care and the control of inflammation of the periodontal tissues throughout 
pregnancy. 
This chapter will review the effect of pregnancy on gingival status and the potential impact 
of gingival inflammation on the unborn child. 
2. Pregnancy gingivitis 
Pregnancy is accompanied by an increase in the production of estrogen and progesterone. 
Initially, the ratio of estrogen and progesterone is 100:1 but during the final months this 
changes to 1:1. Following birth the hormones reach their normal levels within 2 to 3 days 
(Mariotti 1994, Laine 2002). 
Two theories have been proposed for the actions of the hormones on the cells of the 
periodontal tissues: 1) a change in the effectiveness of the epithelial barrier to bacterial insult 
and 2) an effect on collagen turnover (Markou et al. 2009). There are several receptors for 
estrogen and progesterone within the gingival tissue. The estrogen receptors (ERs) exist as 
two subtypes: ERalpha and ERbeta. ERbeta is widely expressed at high levels in oral tissues 
(Välimaa et al.2004). ERbeta is involved in important physiological processes, such as cell 
differentiation, extracellular matrix organization and stromal-epithelial communication 
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(Morani et al. 2008). Estrogen firstly decreases collagen production and keratinization of 
gingival epithelium and secondly induces proliferation of fibroblasts and decreases the 
collagen and no collagen proteins, blocks the turnover of the gingival tissue, thereby 
reducing the capacity of gingival tissue to repair. The result is an increase in the 
permeability of the epithelial barrier and an increased response to plaque bacteria. (Markou 
et al. 2009). Liu et al. (1999) observed a decrease in cellular proliferation of the periodontal 
ligament (PDL). In addition, a decrease in the rate of collagen is mediated by ERbeta. In 
contrast, no immunoreactivity was expressed in these cells for progesterone receptors, 
implying that progesterone does not have a direct effect on the function of PDL cells 
(Jönsson 2007). 
The reactivity for progesterone receptors was observed in gingival fibroblasts (Kawahara & 
Shimazu 2003). Progesterone also has effects on the vascular system favoring an increase in 
gingival exudate and vascular permeability and proliferation; this is possibly due to 
progesterone receptors present in the gingival tissue (Markou et al. 2009). Other factors 
associated with the tissue changes during pregnancy are those related to the fibrinolytic 
system. Fibroblast and macrophages from gingival tissue produce plasminogen activator 
inhibitor type-2 (PAI-2). Several studies had suggested a hormonal influence on the PAI-2 
that disturbs the balance of the fibrinolytic system. A lower inhibitory capacity in terms of a 
low production of PAI-2 associated with progesterone during pregnancy in women with a 
higher inflammatory reaction has been observed and could contribute to gingivitis during 
pregnancy (Kinnby et al.1996). 
3. Pregnancy and the subgingival microflora 
Pregnancy is accompanied by many changes in the composition of the subgingival 
microflora. Jensen et al. (1981) and Korman and Loesche (1980,1982) showed that Prevotella 
intermedia and Prevotella meloninogenica, use either estradiol or progesterone as a substitute 
for napthaquinone (Jensen et al. 1981) and vitamin K (Korman & Loesche 1982), as essential 
growth factors  which encourage a proliferation of  these microorganisms in subgingival 
plaque during pregnancy. 
The correlation between the concentration of hormones in saliva and changes in oral 
microflora during pregnancy are summarized in Table 1. These data provide further 
support for the fact that hormonal changes during pregnancy promote microbiological 
changes in the subgingival flora. Most of these studies found a positive correlation between 
an increase in estradiol and progesterone and an overgrowth of P.intermedia (Korman & 
Loesche 1980, Muramatsu  & Takaesu  1994, Gursoy et al. 2008, Carrillo-de-Albornoz et al. 
2010). A positive correlation was also observed between an overgrowth of Porphyromonas 
gingivalis, Tannerella forshytia (Andriens et al. 2009) and Campylobacter rectus and an increase 
in estradiol concentrations. (Yokoyama et al 2008).  
It has been suggested that microbial changes observed during pregnancy may also occur at 
other sites in the body. High microbial counts in the vagina have been correlated with 
gingivitis in pregnant women when compared with patients without gingival inflammation 
(Person et al. 2009). Correlations between microbiological changes and increased gingival 
inflammation have also been extensively studied. The subgingival microflora increased from 
week 12 of pregnancy, was maintained during the second quarter and reduced during the 
third trimester to postpartum (Korman & Loesche 1980, Muramatsu  & Takaesu  1994, 
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Yokoyama et al. 2008, Andriens et al. 2009). However, some studies had shown that these 
changes can be maintained throughout pregnancy (Gürsoy et al. 2009, Carrillo-de-Albornoz 
et al. 2010). Most of the studies agree that the increase in gingival inflammation occurs in the 
second quarter and is associated with an overgrowth of P. intermedia, (Korman & Loesche 
1980, Muramatsu  & Takaesu  1994).  A correlation was also observed between an increase in 
gingival bleeding and an increase in P. gingivalis and T. forsythia (Andriens et al. 2009). After 
delivery, the levels of bacteria are reduced although, these changes can be sustained 
between 4 to 6 weeks postpartum (Gursoy et al. 2008, Andriens et al.2009). The evidence 
supports the fact that clinical changes during pregnancy are associated with changes in the 
subgingival flora. However, other factors such as an impairement of cellular function and 
immunological changes may also contribute to the increased severity of gingivitis in 
pregnancy. (Figure 1, Figure 2). 
 
 
 
 
 
 
 
 
Fig. 1. A. Prevotella intermedia isolated from a pregnant patient. (Oral Basic Research Unit- 
UIBO, 2010 used for reseach purposes) 
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Fig. 2. Severe gingival changes in a woman with heavy plaque deposits during the second 
trimester (School of Dentistry, Universidad El Bosque, 2010. Used for academic resources) 
 
Authors Population
Design 
of Study
Hormone 
Clinical 
changes 
Time Microorgnims 
Korman & 
Loesche 1980 
USA 
Cross 
Sectional
Estradiol  
progesterone
Gingivitis
Second 
quarter 
P. intermedia 
P.melanogenica 
Muramatsu  & 
Takaesu 1994 
Japan 
Cross 
Sectional
Estradiol  
progesterone
Bleeding 
3 -5    
month 
P. intermedia 
Yokoyama et al 
2008 
Japan 
Cross 
sectional
Estradiol Gingivitis
Second 
quarter 
C. rectus 
Gursoy et al. 2008 Finland Cohort No report Gingivitis
12 weeks 
to end  of 
pregnancy
P. intermedia 
Andriens et al. 
2009 
Switzerland Cohort
Estradiol 
progesterone
Gingivitis
12 – 28 
weeks 
P. gingivalis 
T. forsythensis 
Carrillo de 
Albornoz et al 
2010 
Spain Cohort No report Gingivitis
12 weeks 
to the end 
of 
pregnancy
P. gingivalis 
P. intermedia 
Table 1. Clinical and Microbiological changes in subgingival plaque associated with 
hormonal changes during pregnancy. 
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4. Immunological changes during pregnancy 
Increases in progesterone and prostaglandins modulate the immune system during 
pregnancy. Some degree of immunosuppression occurs during pregnancy which minimizes 
the risk of fetal rejection (Hansen 1988). Maternal tolerance of the fetal allograft could be the 
result of the integration of numerous mechanisms promoted by different cells presented in 
the decidua. Decidual macrophages and dendritic cells, which are found in close association 
with T lymphocytes are the most potent activators of T-lymphocyte responses and could 
play a sentinel function for the immune system, initiating antigen-specific T cell responses to 
fetal antigens (Piccini 2005). Progesterone and glucocorticoids share important anti-
inflammatory and immunosupressive properties and both hormones have potent anti-
proliferative effects in mitogen activation and cytotoxic T cell generation (Stites et al. 1983). 
There is a decrease in CD4/CD8 ratio and peripheral blood lymphocytes and a low 
expression of HLA class I during pregnancy (Szekeres-Bartho et al. 1985). T cell cytokine 
profile could be modulated by the hormones present in the microenvironment; high doses of 
progesterone present at the feto-maternal interface and in the cumulus induce the 
production of IL-4, a strong inducer of Th2 profile which is anti-inflammatory. Progesterone 
also upregulates HLA Class I type G gene expression, which is the NK inhibitory ligand (Yie 
et al. 2006), supresses the proliferation of CD4+ lymphocytes (Bainbridge et al. 2000) and 
induces apoptosis in activated CD8+ Lymphocytes (Fournel et al. 2000). Progesterone also 
down-regulates IL-6 production, rendering the gingiva less efficient at resisting the 
inflammatory challenges produced by bacteria (Lapp et al. 2003). Estradiol and progesterone 
levels increase in saliva during pregnancy, reaching a peak in the third trimester. Levels of 
IL-1 beta and PGE2 showed no significant change in their concentration in crevicular fluid 
during pregnancy. Although their concentrations were higher than non-pregnancy women, 
they did not correlate with clinical changes in gingival tissue (Figuero et al. 2010). However, 
there was an increased concentration of IL1-beta, IL6 and PGE2 in plasma in pregnant 
women with periodontitis, indicating that the presence of the disease can lead to increased 
systemic inflammatory markers (Offenbacher et al. 1998, Ebersole et al. 2010). A decrease in 
neutrophil chemotaxis has been observed during pregnancy, which may be due to the 
effects of sex hormones (Miyagi et al. 1992). These changes in the immune system may 
explain the susceptibility to infection during pregnancy and can support the clinical 
observation of complications in pregnant women with periodontitis. 
5. Gingival changes during pregnancy and their treatment 
The prevalence of gingivitis during pregnancy has been studied in different populations. 
(Ainamo et al. 1982). Studies that have assessed the prevalence of gingivitis during 
pregnancy using the CPITN index are shown in Table 2. The prevalence varies between 67 
to 100%. In some studies, the prevalence and severity is higher in pregnant women when 
compared with non-pregnant women (Nuahma & Annan 1998, Rakchanok 2010). However, 
Miyazaki et al.1991 observed no difference between pregnant and non-pregnant. Studies 
using the CPITN index reported that most pregnant women have calculus and gingival 
inflammation and few women have healthy gingiva during pregnancy. Most pregnant 
women have non-surgical treatment needs and oral hygiene instruction but very few 
require complex periodontal treatment (Table 2). Cohort studies support the evidence that 
pregnancy is associated with gingival changes, (Tilakaratne et al. 2000, Gürsoy et al. 2008, 
Carrillo-de-Albornoz et al. 2010). The clinical indicators evaluated in these studies were 
bleeding on probing and pocket depth without loss attachment, which indicated that this 
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may be due to a more pronounced gingival overgrowth in the proximal surfaces of anterior 
teeth (see figure 2). Few studies have determined the correlation of detectable levels of 
plaque and gingival clinical changes. However, two studies reported the same level of 
dental plaque in pregnant and controls; however, pregnant women responded more 
severely to dental plaque than non pregnant women (Gürsoy et al. 2008, Carrillo-de-
Albornoz et al. 2010). 
The period between weeks 12 and 28 of pregnancy can be characterized by increased 
susceptibility to plaque bacteria and an inflammatory response in the gingiva (Adraiens et 
al. 2009). Studies have not observed loss of attachment during pregnancy, but any pre-
existing periodontitis is exacerbated.(Amar & Chung 1995). Progesterone can reduce local 
production of matrix metalloproteinases and may explain why pregnancy gingivitis may 
not necessarily progress to periodontitis (Laap et al. 1995, Gursoy et al. 2010). Several cohort 
studies had shown that the loss of attachment can be observed during pregnancy and the 
predictor variables are depth of the pockets> 4 mm before week 26 weeks  and  presence of 
bleeding on probing (Moss et al. 2005). Thus, the loss attachment during pregnancy was not 
associated with pre-existing gingivitis, but with the presence of periodontal pockets when 
women became pregnant. During pregnancy, a significant change in tooth mobility can be 
also being observed. The initial mobility is dependent on the degree of vascularization and 
vascular volume of the periodontal ligament. When the female sex hormones act at high 
concentrations for prolonged periods, an increase in the permeability within the periodontal 
vascular system could occur. The resulting edema in the periodontal ligament may result in 
an increase in horizontal tooth mobility in the absence of any loss of periodontal support 
(Mealey & Moritz 2003). 
 
 
 
Table 2. Prevalence, Periodontal status and periodontal treatment needed in pregnant women. 
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Another clinical feature that may arise during the latter stages of pregnancy is the so-
called pyogenic granuloma, (pregnancy tumor or epulis). This occurs in 1 to 5% of 
pregnant women (Amar & Chung 1995). These result from angiogenesis, caused by the 
increased levels of progesterone and the stimulatory effects of estradiol on the connective 
matrix. They usually arise in sites with pre-existing gingivitis (Jafarzadeh et al. 2006), and 
often involve the interdental papilla of one of the maxillary anterior teeth and rarely 
exceed 2 cm in diameter. When they persist they can be surgically remove and their 
removal should be delayed until after delivery. (Jafarzadeh et al. 2006, Rader et al.2008). 
Their removal during pregnancy may be justified if they are continuously traumatized. 
Ideally they should be removed using CO2 or Nd:YAG laser. (Powell et al.1994, 
Lindenmüller et al. 2010). Surgery should only be done when the plaque and gingival 
inflammation have been controlled.  
6. Knowledge, attitudes and practices of pregnant women 
Poor prenatal care during pregnancy is often associated with women from deprived 
backgrounds. Such women have practices, attitudes and knowledge based on beliefs, myths 
and cultural tradition. These false beliefs that pregnancy per se has an adverse effect on the 
teeth and periodontal tissues lead to a lack of self care and deterioration of the oral health of 
these women. Evidence suggests that poor oral health can lead to obstetric problems such as 
low birth weight and preterm delivery (D'Angelo et al.2007, Luce et al. 2011).A number of 
factors influence visits to the dentist during pregnancy such as social, personal and financial 
factors and lack of knowledge of the possible connection between oral health and pregnancy 
outcome (Machuca et al. 1999, Gaffield et al. 2001, Yalcin et al. 2002, Sarlati et al. 2004, 
Acharya & Bhat 2009). However, an assessment of pregnant women with a relatively high 
socioeconomic status in the U.S. found that 49% of respondents reported having attended a 
dentist, and 43% were aware of the connection between oral health and pregnancy 
outcomes. (Huebner et al.2009. This suggests that better education focused on the 
importance of dental care before and during pregnancy should be provided to prevent 
future complications. (Al Habashneh et al. 2005). 
We assessed the level of knowledge and oral health practices in pregnant women in a low 
socioeconomic population in Bogota, Colombia. The study showed that most pregnant 
women had good knowledge of the major oral diseases and how to prevent them; however, 
knowledge about the associations between pregnancy and perinatal complications were 
limited. Over 60% had attended the dentist during pregnancy and more than 50% claimed 
that they had received advice from their doctors and had been recommended to visit their 
dentist. However, they were not informed about the potential effect of changes in the mouth 
during pregnancy and the risk for pregnancy complications. In general, these women were 
from lower socioeconomic communities and the majority of women claimed to brush their 
teeth frequently and 35% used dental floss. These women had not perceived significant 
changes, such as gingival bleeding and swelling, during pregnancy. Women being treated at 
the community clinic, expressed fears of having radiographs, extractions and local 
anaesthesia during pregnancy. This study observed a significant improvement in the 
perception of oral health in a population that regularly attended public services and showed 
the impact of oral health care guide implemented in these public hospitals and emphasizes 
the importance of pre-conceptional preventive practices that improve the oral health of 
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women before they enter the pregnancy to minimize gingival and periodontal changes 
associated with this condition.(Lafaurie et al. 2011, unpublished data) 
Another factor that influences health care during pregnancy is the low awareness amongst 
health care professionals of the changes that can occur in the oral cavity during 
pregnancy.There is clearly a need to provide health personnels with information on the 
importance of oral care during pregnancy (Al-Habashneh et al. 2008, Huebner et al. 2009, 
Salama et al. 2010).   
7. Treatment of gingivitis during pregnancy 
Few studies have assessed the effect of treatment on gingivitis during pregnancy. Most 
studies have evaluated the safety and effect of periodontal treatment on pregnant women 
with periodontitis. However, Lopez et al. (2005) assessed the safety and effect of treatment of 
gingivitis during pregnancy and found an increased risk of complications such as pre-term 
birth (PPT) and low birth weight (LBW) in women who were not treated. 
The American Heart Association (AHA) guidelines for prevention of infective endocarditis 
report that bacteremia associated with oral bacteria was often associated with the patient’s 
routine activities, such as chewing, tooth brushing and after therapeutic procedures (Wilson 
et al. 2008). Several studies have evaluated the presence of bacteremia in patients by 
mechanical stimuli such as brushing and flossing (Lockhart et al. 2008, Castra et al. 2009).), 
chewing (Geerts et al.2002, Ide et al.2004) and ultrasonic scaling (Forner et al. 2006, Kinane et 
al. 2005). The studies showed that pregnant women with high levels of gingival 
inflammation can be exposed to bacteremia arising from the mouth. 
Once oral bacteria gain access to blood vessels they can cross the placental barrier. Subgingival 
bacteria increase in pregnancy gingivitis, as it had been reported that Streptococcus ssp. and 
Fusobacterium nucleatum have been cultured from amniotic fluid in pregnant women (Bearfield 
et al. 2002). An increase of IgM antibodies to F. nucleatum, P. intermedia and C. rectus in fetal 
cord blood, were significantly higher for preterm as compared to full-term neonates. It has 
been suggested that fetal infections by these microorganism may be related to prematurity 
(Madianos et al. 2001). Fardini et al. (2010) injected bacteria obtained from human saliva and 
dental plaque into pregnant rats. They demonstrated that a wide range of oral microorganisms 
may be associated with intrauterine infection. 
Given the evidence that periodontal status is associated with complications of pregnancy, 
some countries have started the implementation of technical standards and guidelines of 
care which includes oral care during pregnancy. The guideline developed by the State of 
California has been widely used in clinical practice and has been adapted by other states in 
the USA (Kumar J, Samuelson 2009). Such guidelines emphasize the need for the care of 
pregnant women and include the time the treatments to be performed, medications given 
during pregnancy and indications and contraindications for certain procedures.  
The recommendations for periodontal treatment are as follows: 
7.1 Dental treatment should be as frequent as possible during the second trimester (weeks 12 
to 28) of pregnancy. However, some studies emphasize that gingival inflammation should 
be reduced early in pregnancy. Treatment, such as   scaling and root planing can be 
performed from week 8 without increased risk for pregnancy (Lopez et al. 2002, 2005).  
7.2 Diagnostic X-rays during pregnancy are safe and can improve the assessment of 
periodontal status. A panel of experts from the Food and Drug Administration (FDA) 
www.intechopen.com
 
Gingival Tissue and Pregnancy 
 
109 
concluded that the recommendations regarding the use of oral radiographs should not be 
altered because a patient is pregnant (American Dental Association, 2010). The number and 
type of radiographs depends on the clinical condition and the patient's medical history. As a 
standard practice for taking radiographs the patient should be protected with a vest that 
covers the neck and abdomen. 
7.3 Most periodontal therapy can be performed with local anesthesia and it is important to 
note that this does not increase adverse fetal outcomes. Most of the anesthetics used in 
dentistry are classified as Class B by the FDA. However, mepivacaine and bupivacaine are 
classified as class C and are contraindicated in pregnancy. Local anesthetics cross the 
placental barrier by passive diffusion but are not teratogenic (Hool 2010). Although 
epinephrine is not teratogenic intravascular injection can be avoided by correctly aspirating 
with the syringe. (Martin & Varner 1994). Before the use of vasoconstrictors the blood 
pressure should be measured because of hypertension during pregnancy occurs between 6 
and 10% of pregnancies. 
Although these treatment guidelines exist for pregnant women, there are no specific 
protocols for the treatment of gingival inflammation in pregnant women. All the evidence, 
including work from our group, indicates that periodontal treatment can induce a 
bacteremia in patients with severe periodontal disease (Lafaurie et al. 2007, Castillo et al. 
2011). Although most pregnant women have gingivitis during pregnancy the degree of 
inflammation can vary from mild to severe. The needs for management protocols for 
pregnant women with have not yet been defined. There are no clear regulations on the use 
of antiplaque products during pregnancy. Toothpastes containing triclosan have been 
reported to reduce gingivitis during pregnancy (Kraivaphan et al. 2009). Clorhexidine has 
been associated with a reduction in cellular proliferation in vitro (Marioti et al. 1999) and 
desquamation of the mucosa had been reported (Jones 1997). Mouthwashes, such as 
chlorhexidine, have been used only once a day as part of periodontal therapy in women 
with gingivitis during pregnany (Lopez et al. 2002, 2005). Based on this evidence it seems 
beneficial to use mouthwashes and toothpastes containing anti-plaque agents in patients 
with high levels of gingival inflammation.  
8. Gingival status, gestational diabetes and perinatal complications 
A perinatal risk factor is any biological property, environmental or social, which when 
present is associated with increased probability of an adverse event, either in the fetus, the 
mother, or both. Early identification of risk factors may allow strategic planning of prenatal 
care. Prematurity is the leading cause of neonatal morbidity and mortality worldwide and 
the frequency varies between populations. The World Health Organization (WHO) in 2000 
estimated the prevalence of LBW is approximately 15.5% (7% for most developed countries, 
16.5% for those in developing counties. The prevalence determined for each of the regions 
established by the United Nations was: Africa 14.3% Asia 18.3%, 6.4% Europe, Latin 
America and the Caribbean 10%, 7.7% North America, and Oceania 10.5%. The risk of a 
premature infant dying is 180 times greater than that of a full term baby and those that 
survive have an increased risk of disability. The World Health Organization in 1976 defined 
low birth weight (LBW)   as below 2,500 grams (5.5 pounds) regardless of gestational age 
and defines pre-term delivery (PPT) as before 37 weeks of gestation.  
Many factors have been associated with LBW and PPT. They include socio-demographic 
factors, maternal age <18 and> 35 years, black race, low socioeconomic status and lack of 
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access to health services. All have shown to increase the risk for these perinatal 
complications (Elster 1984. Buescher & Mittal 2006, Rosenthal & Lobel 2011). Other 
associated factors include a history of PPT prior to 35 weeks gestational age, placental 
ischemia, premature rupture of membranes and cervical incompetence and complications 
during pregnancy ,such as  genito-urinary infections, multiple gestation, bleeding in the 
second half of pregnancy and polyhydroamnios have been considered as predictors for 
LBW and PPT ( McCormick 1985, Ferraz et al.1990,  Alexander &. Korenbrot 1995, Kramer et 
al.1987, Heaman et al. 2008). Aspects related to the lifestyle, the consumption of snuff, 
alcohol and psychoactive substances and nutritional and psychosocial factors also increase 
the risk of perinatal complications. (Kogan 1995, Farrell et al.2006, Lederman 2011).  
Periodontal status during pregnancy has also been associated with perinatal complications. 
Numerous cohort studies have been conducted to evaluate the risk association between 
periodontitis and pregnancy complications (Lopez et al. 2002, Moreu et al. 2004, Pitiphat et al, 
2008. Saddki  et al. 2008, Agueda et al. 2008). Three systematic reviews demonstrate an 
increased risk for PPT, LBW  and low birth-weight with preterm birth and intrauterine 
growth restriction in individuals with periodontitis  (Xiong et al.2007, Khader & Ta'ani 2005, 
Vergnes & Sixou M  2007). The risk varies between populations but in most studies the 
presence of periodontitis shown to be an independent risk factor for these complications.  
Several studies have identified microorganisms associated with periodontal infections such 
as P. gingivalis, Actinobacillus actinomycetemcomitans, F. nucleatum. , P. intermedia, T. forsythia 
and Treponema denticola in samples of placenta of women with preterm labor and 
preeclampsia. (Barak et al. 2007, León et al. 2007). The proteolytic capacity of these 
microorganisms and their ability to activate systemic proinflammatory mechanisms, 
facilitate these perinatal complications. Two periodontal organisms have been specially 
associated with LBW; C. rectus and P. gingivalis. Rat fetuses exposed to infection with C. 
rectus showed a decreased size and weight compared to a control group (Yeo et al. 2007, 
Simor et al. 1986, O'Sullivan et al. 1988). Associations between periodontal disease and LBW 
and PPT were explained also by relating the physiological processes that lead to the time of 
delivery as periodontal infection lead to increased serum levels of PGE2, TNF, IL 1 ß, IL6, 
which trigger a series event such as cervical dilation, uterine contractions start and the 
activation of metalloproteinases that generate the breakdown of amniochorion. It seems 
likely, that periodontal disease could lead to preterm delivery (Damare  et al. 1997, 
Offenbacher et al. 1998, Dörtbudak et al. 2005, Ebersole et al. 2010). 
Although a risk association between periodontitis and pregnancy complications is accepted, 
intervention studies comparing individuals treated with scaling and root planing with a 
control non treated group have proved to be conflicting. Three trials reported that treatment 
reduced the complications of pregnancy, (Lopez et al. 2002; Tarannum &, Faizuddin 2007; 
Offenbacher et al. 2006). 4 studies in developed countries, however, failed to find an effect 
on pregnancy complications (Jeffcoat et al. 2005, Michalowicz et al. 2006, Newnham et al. 
2009 Offenbacher et al. 2009). However, the studies differed in many respects:  The type of 
population, sample size, presence of other perinatal risks, treatment received and by whom, 
and the weeks of gestation when the treatment took place. A systematic review (Polyzos et 
al. 2008 ) which evaluated 7 intervention studies found that scaling and root planing showed 
a protective effect for PPT OR 0.55 (0.35 to 0.87) but not for LBW OR 0.48 (0.23 to 1). The 
effect of treatment was significantly higher in patients without a history of PPT or LBW OR 
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0.48 (0.29 to 0.77) and a mild disease OR 0.49 (0.28 to 0.87). In 2010, the authors included 
another 3 studies in highly developed countries and show a loss of the protective effect of 
the periodontal treatment on perinatal complications (Polyzos et al. 2010). 
Although the evidence is controversial, the periodontal treatment is a safe procedure and 
should be performed early in pregnancy between weeks 8 to 28. However it is important to 
further evaluate the treatment of advanced periodontal disease in patients with high 
perinatal risk. The most evidence-based studies show that periodontal treatment during 
pregnancy reduces further loss of attachment and improves the clinical status of the 
periodontium during pregnancy. 
9. Periodontal status in high-risk women 
Three conditions must be reviewed in relation to periodontal status and treatment needs 
during pregnancy. 
9.1 Previous history of preterm delivery (PPT) and low birth weight (BWT) 
The history of PPT and BWT is the most important risk factor for perinatal complications. 
The evidence indicates that periodontal treatment fails to reduce the incidence of pregnancy 
complications in patients with a history of PPT and LBW, It, It is necessary to review the 
protocols for periodontal management in patients with high levels of gingival inflammation. 
The use of antibiotics in chronic infections during pregnancy has been studied. The evidence 
indicates that antibiotics are safe during pregnancy and reduce perinatal complications 
(McDonald et al. 2007). Since gingival inflammation is associated with a polymicrobial flora, 
broad-spectrum antibiotics may be preferable in the treatment of pregnant women at 
perinatal risk. Beta-lactam antibiotics such as penicillin and cephalosporins are the drugs of 
choice. They are categorized as class B drugs by the FDA, cross the placenta, but are 
considered safe for the fetus (Nahum et al. 2006) If the patient is allergic to penicillin a 
macrolide antibiotic such as erythromycin, clindamycin and azithromycin, which are rated B 
by the FDA may be prescribed (Crider et al. 2009). However, antibiotics are only indicated 
in high-risk perinatal patients with high levels of inflammation and requiring extensive 
scaling and root planing. The use of antibiotics in these patients is warranted to control the 
high degree of bacteremia during mechanical treatment. The American Gynecology and 
Obstetrics Association suggest the following scheme for the prevention of infective 
endocarditis in pregnant women: 
 Ampicillin 2 g intravenously 1 hour or 30 minutes before the procedure 
 Cefazolin 1 g IV 1 hour or 30 minutes before the procedure 
 Amoxicillin 2 g orally 1 hour or 30 minutes before the procedure  
 Clindamycin 600mg 1 hour 30 min or earlier in patients who are allergic to penicillin 
9.2 Hypertensive disorders of pregnancy 
The prevalence of hypertension during pregnancy is between 6 and 10%. Hypertensive 
diseases and preeclampsia in particular are a cause of morbidity and perinatal and maternal 
mortality. They are more common in developing countries. The effect of periodontal 
infection on the incidence of preeclampsia has been evaluated in cohort studies. A 
systematic review showed an OR 1.76, 95% CI: 1.43-2.18, in women with preeclampsia 
compared with pregnant women without preeclampsia; the presence of periodontitis 
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increased the risk of perinatal complication (Vergnes et al. 2008). Because of the association 
between periodontitis and preeclampsia it is important that the periodontal status of 
pregnant women with preeclampsia risk are assessed in early pregnancy and treated before 
20 weeks before presenting the early signs of this condition. 
9.3 Gestational Diabetes 
Gestational Diabetes Mellitus (GDM) is a carbohydrate intolerance of variable severity first 
recognized during pregnancy. Prevalence of GDM has been reported between 8 al 16%. 
(Moses et al. 2001, Chodick et al. 2011). Women with diabetes and with a past history of 
gestational diabetes, age > 40 and a body mass index  > 35 Kg/m (BMI) are the most 
important factors for GDM during pregnancy (Teh et al. 2011). Women with gestational 
diabetes had a higher mean plaque index and higher mean gingival index than healthy 
pregnant women (Mittas et al. 2006). Patients with GDM and pregestational obesity had 
significantly more gingivitis and periodontal attachment loss that those with normal 
pregestational BMI. (Guthmiller et al. 2001, Chapper et al. 2005). Periodontal treatment 
should be considered when establishing future recommendations for metabolic control for 
this group of patients. However, in many cases, the periodontal treatment may be required 
by patients without good metabolic control with high levels of glycated hemoglobin 
(HbA1c) ≥ 8.0). In these uncontrolled diabetic patients with active periodontal disease, the 
first phase of treatment is to reduce levels of inflammation and prevent hyperglycemia 
produced by pain and stress of infection. The patient should be referred to a physician for a 
review of their metabolic control (Vermillo 2003.). Well controlled patients may be treated 
with conventional periodontal treatment. The use of antibiotics for periodontal treatment 
should be considered in these patients after consultation with their physician. Clinical 
protocols for gestational Diabetes Mellitus should be developed. 
10. Conclusion and recommendations 
Gingivitis during pregnancy is exacerbated by the hormonal changes that affect the host’s 
responses to dental plaque. Ideally oral health policies and guidelines should be developed 
for the oral care of women before becoming pregnant. The treatment of gingivitis should 
commence at an early stage of the pregnancy to minimize the risk of more severe disease at 
a later stage. However, in high risk patient’s treatment of periodontal disease should be 
undertaken with caution and the use of antibiotics may be recommended. Periodontal 
treatment improves the oral conditions of pregnant women and could help reduce perinatal 
complications. 
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